Literature DB >> 20391116

Ozone increases airway hyperreactivity and mucus hyperproduction in mice previously exposed to allergen.

Søren T Larsen1, Shigeki Matsubara, Glen McConville, Steen S Poulsen, Erwin W Gelfand.   

Abstract

Acute exacerbations of asthma represent a common clinical problem with major economic impact. Air pollutants including ozone have been shown to contribute to asthma exacerbation, but the mechanisms underlying ozone-induced asthma exacerbation are only partially understood. The present study aimed to develop a mouse model to gain insight into the development of airway hyperresponsiveness (AHR) to methacholine (MCh) in mice after exposure to both allergen and ozone. Mice were exposed for 20 min per day for 10 consecutive days to an aerosol of 1% ovalbumin (OVA) or saline followed by a single 3-h exposure to clean air or 100, 250, or 500 ppb ozone. Ozone induced AHR in mice previously exposed to OVA when compared to non-exposed (saline) control mice. After a 10-d exposure to OVA, a single exposure to a low (100 ppb) ozone concentration was sufficient to induce AHR. The AHR response was associated with goblet-cell metaplasia. Even the lowest concentration of ozone tested, 100 ppb, which may be exceeded in urban environments and in the workplace, resulted in a significant increase in AHR, most prominent 24 h after exposure in the OVA-exposed mice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20391116     DOI: 10.1080/15287391003614034

Source DB:  PubMed          Journal:  J Toxicol Environ Health A        ISSN: 0098-4108


  10 in total

Review 1.  Air pollution exposure: a novel environmental risk factor for interstitial lung disease?

Authors:  Kerri A Johannson; John R Balmes; Harold R Collard
Journal:  Chest       Date:  2015-04       Impact factor: 9.410

Review 2.  Spectrum of T-lymphocyte activities regulating allergic lung inflammation.

Authors:  Erwin W Gelfand; Anthony Joetham; Meiqin Wang; Katsuyuki Takeda; Michaela Schedel
Journal:  Immunol Rev       Date:  2017-07       Impact factor: 12.988

3.  Health benefits from large-scale ozone reduction in the United States.

Authors:  Jesse D Berman; Neal Fann; John W Hollingsworth; Kent E Pinkerton; William N Rom; Anthony M Szema; Patrick N Breysse; Ronald H White; Frank C Curriero
Journal:  Environ Health Perspect       Date:  2012-07-18       Impact factor: 9.031

4.  SERCA2 regulates non-CF and CF airway epithelial cell response to ozone.

Authors:  Shama Ahmad; David P Nichols; Matthew Strand; Raymond C Rancourt; Scott H Randell; Carl W White; Aftab Ahmad
Journal:  PLoS One       Date:  2011-11-11       Impact factor: 3.240

Review 5.  Interstitial Lung Diseases in Developing Countries.

Authors:  Pilar Rivera-Ortega; Maria Molina-Molina
Journal:  Ann Glob Health       Date:  2019-01-22       Impact factor: 2.462

Review 6.  Interstitial Lung Diseases and Air Pollution: Narrative Review of Literature.

Authors:  Nishtha Singh; Sheetu Singh
Journal:  Pulm Ther       Date:  2021-03-10

7.  Air quality index variation before and after the onset of COVID-19 pandemic: a comprehensive study on 87 capital, industrial and polluted cities of the world.

Authors:  Mohammad Sarmadi; Sajjad Rahimi; Mina Rezaei; Daryoush Sanaei; Mostafa Dianatinasab
Journal:  Environ Sci Eur       Date:  2021-12-05       Impact factor: 5.893

8.  The murine lung microbiome in relation to the intestinal and vaginal bacterial communities.

Authors:  Kenneth Klingenberg Barfod; Michael Roggenbuck; Lars Hestbjerg Hansen; Susanne Schjørring; Søren Thor Larsen; Søren Johannes Sørensen; Karen Angeliki Krogfelt
Journal:  BMC Microbiol       Date:  2013-12-28       Impact factor: 3.605

9.  Impact of ozone exposure on the response to glucocorticoid in a mouse model of asthma: involvements of p38 MAPK and MKP-1.

Authors:  Aihua Bao; Feng Li; Min Zhang; Yuqing Chen; Pengyu Zhang; Xin Zhou
Journal:  Respir Res       Date:  2014-10-08

10.  Effects of Ammonium Chloride on Ozone-induced Airway Inflammation: the Role of Slc26a4 in the Lungs of Mice.

Authors:  Jong Uk Lee; Hyeon Ju Lee; Ji Na Kim; Min Kyung Kim; Sung Roul Kim; Hun Soo Chang; Choon Sik Park; Jong Sook Park
Journal:  J Korean Med Sci       Date:  2020-08-17       Impact factor: 2.153

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.